Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

2.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

3.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
4.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
5.

Screening for colon cancer: A test for occult blood.

Khakimov N, Khasanova G, Ershova K, Gibadullina L, Vetkina T, Lobisheva G, Chumakova A.

Int J Risk Saf Med. 2015;27 Suppl 1:S110-1. doi: 10.3233/JRS-150712.

PMID:
26639687
6.

Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.

Regge D, Iussich G, Senore C, Correale L, Hassan C, Bert A, Montemezzi S, Segnan N.

Trials. 2014 Mar 28;15:97. doi: 10.1186/1745-6215-15-97.

7.

Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.

Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW.

Cancer. 2016 Jan 15;122(2):312-21. doi: 10.1002/cncr.29734. Epub 2015 Oct 21.

8.

Fecal occult blood testing: a false sense of security?

Schnell T, Aranha GV, Sontag SJ, Tode R, Reid S, Chejfec G, Karpf J, Levine G.

Surgery. 1994 Oct;116(4):798-802; discussion 802-3.

PMID:
7940181
9.

Colorectal cancer test use--Maryland, 2002-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Sep 14;56(36):932-6.

10.

Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.

Kubisch CH, Crispin A, Mansmann U, Göke B, Kolligs FT.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1612-1618.e3. doi: 10.1016/j.cgh.2016.04.008. Epub 2016 Apr 13.

PMID:
27085763
11.

Participation in colorectal cancer screening: a review.

Vernon SW.

J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22. Review.

PMID:
9326910
12.

Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.

Honein-AbouHaidar GN, Baxter NN, Moineddin R, Urbach DR, Rabeneck L, Bierman AS.

Cancer Epidemiol. 2013 Dec;37(6):946-56. doi: 10.1016/j.canep.2013.04.007. Epub 2013 May 20.

PMID:
23702337
13.

Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.

Parente F, Marino B, Ardizzoia A, Ucci G, Ilardo A, Limonta F, Villani P, Moretti R, Zucchi A, Cremaschini M, Pirola ME.

Am J Gastroenterol. 2011 Nov;106(11):1986-93. doi: 10.1038/ajg.2011.185. Epub 2011 Jun 14.

PMID:
21670773
14.

[Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].

Webendörfer S, Riemann JF.

Dtsch Med Wochenschr. 2014 Jan;139(3):79-83. doi: 10.1055/s-0033-1349588. Epub 2013 Oct 2. German.

PMID:
24089288
15.

Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.

Daniels K, McKee M.

J R Army Med Corps. 1995 Oct;141(3):142-50. Erratum in: J R Army Med Corps 1996 Feb;142(1):49.

PMID:
8568748
16.

The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening.

Hubbard RA, Johnson E, Hsia R, Rutter CM.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1612-9. doi: 10.1158/1055-9965.EPI-13-0254. Epub 2013 Jul 18.

17.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380. Epub 2012 Dec 18.

PMID:
23247579
18.

How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Haug U, Knudsen AB, Kuntz KM.

Int J Cancer. 2012 Nov 1;131(9):2094-102. doi: 10.1002/ijc.27463. Epub 2012 Mar 29.

19.

Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.

Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, Moretti R, Cremaschini M, Parente EM, Pirola ME.

Endoscopy. 2013;45(1):27-34. doi: 10.1055/s-0032-1325800. Epub 2012 Dec 19.

PMID:
23254404
20.

Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives.

Liles EG, Schneider JL, Feldstein AC, Mosen DM, Perrin N, Rosales AG, Smith DH.

Implement Sci. 2015 Mar 29;10:41. doi: 10.1186/s13012-015-0227-z.

Supplemental Content

Support Center